Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2023-08-09 | Kvartalsrapport 2023-Q2 |
| 2023-06-15 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2023-06-14 | Årsstämma 2023 |
| 2023-03-22 | Bokslutskommuniké 2022 |
| 2022-08-10 | Kvartalsrapport 2022-Q2 |
| 2022-06-16 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2022-06-15 | Årsstämma 2022 |
| 2022-03-09 | Extra Bolagsstämma 2022 |
| 2022-02-16 | Bokslutskommuniké 2021 |
| 2021-08-11 | Kvartalsrapport 2021-Q2 |
| 2021-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2021-04-21 | Årsstämma 2021 |
| 2021-02-17 | Bokslutskommuniké 2020 |
| 2020-08-12 | Kvartalsrapport 2020-Q2 |
| 2020-04-23 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2020-04-22 | Årsstämma 2020 |
| 2020-02-19 | Bokslutskommuniké 2019 |
| 2019-08-14 | Kvartalsrapport 2019-Q2 |
| 2019-04-25 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2019-04-24 | Årsstämma 2019 |
| 2019-02-20 | Bokslutskommuniké 2018 |
| 2018-08-22 | Kvartalsrapport 2018-Q2 |
| 2018-08-16 | Extra Bolagsstämma 2018 |
| 2018-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2018-04-25 | Årsstämma 2018 |
| 2018-02-28 | Bokslutskommuniké 2017 |
| 2017-07-27 | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2017-04-26 | Årsstämma 2017 |
| 2017-02-02 | Bokslutskommuniké 2016 |
| 2016-10-20 | 15-10 2016-Q3 |
| 2016-08-10 | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | Kvartalsrapport 2016-Q1 |
| 2016-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2016-04-25 | Årsstämma 2016 |
| 2016-02-25 | Bokslutskommuniké 2015 |
| 2015-10-22 | Kvartalsrapport 2015-Q3 |
| 2015-08-20 | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | Kvartalsrapport 2015-Q1 |
| 2015-04-21 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2015-04-20 | Årsstämma 2015 |
| 2015-02-26 | Bokslutskommuniké 2014 |
| 2014-10-23 | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-04-15 | Ordinarie utdelning BIOBV 0.72 EUR |
| 2014-04-14 | Årsstämma 2014 |
| 2014-02-27 | Bokslutskommuniké 2013 |
| 2013-10-24 | Kvartalsrapport 2013-Q3 |
| 2013-08-08 | Kvartalsrapport 2013-Q2 |
| 2013-04-25 | Kvartalsrapport 2013-Q1 |
| 2013-04-09 | Ordinarie utdelning BIOBV 0.50 EUR |
| 2013-04-08 | Årsstämma 2013 |
| 2013-02-27 | Bokslutskommuniké 2012 |
| 2012-10-25 | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | Kvartalsrapport 2012-Q2 |
| 2012-04-26 | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | Ordinarie utdelning BIOBV 1.00 EUR |
| 2012-04-11 | Årsstämma 2012 |
| 2012-02-29 | Bokslutskommuniké 2011 |
| 2011-11-23 | Extra Bolagsstämma 2011 |
| 2011-10-20 | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | Kvartalsrapport 2011-Q2 |
| 2011-04-14 | Ordinarie utdelning |
| 2010-04-26 | Ordinarie utdelning |
| 2009-04-21 | Ordinarie utdelning |
| 2008-04-22 | Ordinarie utdelning |
| 2007-04-20 | Ordinarie utdelning |
| 2006-04-21 | Ordinarie utdelning |
| 2005-04-22 | Ordinarie utdelning |
| 2004-04-16 | Ordinarie utdelning |
| 2003-04-10 | Ordinarie utdelning |
| 2002-04-02 | Ordinarie utdelning |
| 2001-03-28 | Ordinarie utdelning |
| 2000-04-07 | Ordinarie utdelning |
| 1999-04-22 | Ordinarie utdelning |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Biohit Oyj Stock Exchange Release 10 March 2022 at 10:00 am local time (EET)
Biohit Oyj ("Company") and Biohit HealthCare (Hefei) Co. Ltd. ("Hefei") have on 8 February 2022 entered into a security agreement. Pursuant to such agreement, Hefei has pledged to the Company 1,500,000 class B shares in the Company as security for its obligations referred to therein (the "Hefei Pledge").
Company's extraordinary general meeting of shareholders has on 9 March 2022 resolved to authorize the Board of Directors to resolve on accepting a maximum total amount of 3,000,000 class B shares in the Company as pledge on the terms deemed fit by the Board of Directors.
Extraordinary general meeting also decided to authorize the Board of Directors to decide on the issue of a maximum total amount of 3,000,000 class B shares in the company by way of derogation from the shareholders' pre-emptive subscription rights. The class B shares to be issued must consist of the own shares pledged to the company.
The Board of Directors of the Company decided on 9 March 2022, in accordance with the security agreement and authorization referred to above, resolved to accept the Hefei Pledge.
Additional information:
Päivi Siltala, CEO
Tel. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi